Experienced in Chondrosarcoma

Zhengang A. Zha

Key Laboratory Of Regenerative Medicine Of Ministry Of Education, 
Guangzhou, CN 
Experienced in Chondrosarcoma
Key Laboratory Of Regenerative Medicine Of Ministry Of Education, 
Guangzhou, CN 
OverviewLocationsClinical Research

Overview

Zhengang Zha practices in Guangzhou, China. Zha is rated as an Experienced expert by MediFind in the treatment of Chondrosarcoma. Their top areas of expertise are Osteoarthritis, Arthritis, Chondrosarcoma, and Osteosarcoma.

Their clinical research consists of co-authoring 54 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Chondrosarcoma.

Locations

Key Laboratory Of Regenerative Medicine Of Ministry Of Education, Guangzhou, 510630, China
Other Locations
Zhengzhou, 450052, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double Blind, Multi Center, Active-controlled, 2 Treatment Arm, Parallel Group Non Inferiority Study to Evaluate the Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel Versus 1.16% Gel in Subjects With Acute Ankle Sprain
A Randomized, Double Blind, Multi Center, Active-controlled, 2 Treatment Arm, Parallel Group Non Inferiority Study to Evaluate the Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel Versus 1.16% Gel in Subjects With Acute Ankle Sprain
Enrollment Status: Completed
Publish Date: April 12, 2022
Intervention Type: Drug, Other
Study Phase: Phase 3

54 Total Publications

Trim21 deficiency alleviates osteoporosis by inhibiting osteoclast differentiation through regulating Txnip.
Trim21 deficiency alleviates osteoporosis by inhibiting osteoclast differentiation through regulating Txnip.
Journal: Arthritis research & therapy
Published: January 29, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zha's expertise for a condition
ConditionClose
      View All 8 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile